Worth up to 15.00 credits!
Available Credits: ACPE-P/T, AMA, ANCC, CCMC, and Attendance
Start Date: August 9, 2019
Expiration Date: August 9, 2021

Intended audience
These activities are designed to meet the educational needs of case managers, nurses, pharmacists, pharmacy technicians, physicians and other health care professionals (HCPs) who are interested in the care and management of oncology, solid organ and blood/marrow transplantation patient populations.

Activity Description
These activities consist of recordings from the "Essentials of Oncology, Solid Organ and Blood/Marrow Transplant Management for the Health Care Team" held April 11–12, 2019, in Scottsdale, Ariz.

Throughout these activities, faculty will discuss the keys to optimize the management/benefits of individuals with cancer and/or undergoing organ or blood/marrow transplant. Participants will hear about advances, trends and updates on relevant topics within these fields, such as medical, psychosocial and surgical transplant management; infectious disease; changes to the national policy on organ allocation; and chimeric antigen receptor (CAR) T-cell therapy. Participants will learn about the latest guidelines and future applications in transplantation and cancer care, and discover current and emerging strategies to adapt standards and best practices to improve patient care and outcomes.

Learning Objectives
At the end of these educational activities, participants should be able to:

  • Describe new advances in the treatment of acute myeloid leukemia (AML) and the role of transplantation for multiple myeloma and autoimmune diseases.
  • State the potential impact of normothermic liver preservation on transplant outcomes and waiting list mortality.
  • Recognize the clinical and financial impact of commercially available CAR T-cell therapy.
  • Discuss current research and best-practice standards in pediatric blood/marrow transplant (BMT) and explore transplant barriers to access.
  • List the various types of opportunistic infections in immunocompromised individuals.
  • Explain the various approaches in the medical, psychosocial, and surgical management of heart, lung, kidney, and liver transplantation.
  • Outline recent changes to the adult heart allocation policy and how these changes impact waitlist mortality, outcomes, and provider and patient satisfaction, as well as address the implications for those with ventricular-assist-devices (VADs) as long-term alternatives to transplant.
  • State current and new therapeutic approaches for hepatocellular carcinoma treatment outside of transplant, and describe various bridging treatment techniques to transplant.
  • Address some of the ethical and/or controversial issues surrounding liver transplantation for patients with alcoholic hepatitis.

Click on the activity title for more information or to view.

Liver Transplantation for Patients with Alcoholic Hepatitis
Michael Abecassis, MD, MBA
J. Roscoe Miller Distinguished Professor
Departments of Surgery and Microbiology/Immunology
Feinberg School of Medicine, Northwestern University;
Chief, Division of Organ Transplantation
Northwestern Memorial Hospital;
Founding Director, Comprehensive Transplant Center
Northwestern University
Chicago, IL
1.00 credit

Opportunistic Infections in the Immunocompromised
Jeffery J. Auletta, MD
Professor, Department of Pediatrics
The Ohio State University College of Medicine;
The Ohio State University Comprehensive Cancer Center;
Director, Host Defense Program
Director, Blood and Marrow Transplant Program
Hematology/Oncology/BMT & Infectious Diseases
Nationwide Children’s Hospital
Columbus, OH
1.00 credit

Increasing Kidneys for Transplantation: Decreasing Discards
Matthew Cooper, MD
Professor of Surgery
Georgetown University School of Medicine;
Director, Kidney and Pancreas Transplantation
Medstar Georgetown Transplant Institute
Washington, DC
1.00 credit

Pediatric Blood/Marrow Transplant Overview
Reggie E. Duerst, MD
Associate Professor
Feinberg School of Medicine, Northwestern University;
Clinical Director, Stem Cell Transplant Program
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, IL
1.00 credit

Updates on Heart Failure Management:
Innovations in Left Ventricular Assist Devices for End-stage Heart Failure and New Allocation Policy for Heart Transplant

Jerry Estep, MD
Section Head,
George M. and Linda H. Kaufman Center for Heart Failure Treatment and Recovery;
Cleveland Clinic
Cleveland, OH
1.00 credit

Normothermic Liver Preservation: Current Status and Future Directions
R. Mark Ghobrial, MD, PhD, FACS, FRCS
Sherrie and Alan Conover Chair for Excellence in Liver Transplantation
Sherrie and Alan Conover Center for Liver Disease & Transplantation;
Professor of Surgery, Institute for Academic Medicine
Full Member, Research Institute
Weill Cornell Medical College;
Houston Methodist
Houston, TX
1.00 credit

Psychosocial Evaluation of Adult Cardiothoracic Transplant Candidates and Candidates for Long-term Mechanical Circulatory Support
Kathleen L. Grady, PhD, RN, MS, FAAN
Professor of Surgery and Medicine
Feinberg School of Medicine, Northwestern University;
Administrative Director, Center for Heart Failure
Bluhm Cardiovascular Institute
Division of Cardiac Surgery
Northwestern Memorial Hospital
Chicago, IL
1.00 credit

Acute Myelogenous Leukemia: New Therapies after 40 Years!
Fiona He, MD
Assistant Professor of Medicine
Division of Hematology, Oncology and Transplantation
University of Minnesota
Minneapolis, MN
1.00 credit

Multiple Myeloma: What’s New in Treatment Options
Jonathan L. Kaufman, MD
Associate Professor,
Hematology and Medical Oncology
Winship Cancer Institute
Emory University School of Medicine
Atlanta, GA
1.00 credit

Non-HLA Barriers to Blood/Marrow Transplant
Nandita Khera, MD, MPH
Assistant Professor of Medicine
Mayo Clinic College of Medicine and Science
Scottsdale, AZ
1.00 credit

CAR T-cell Therapy: A Personalized Immunotherapy Approach to Cancer
Shannon L. Maude, MD, PhD
Assistant Professor of Pediatrics
Fellowship Director, Cancer Immunotherapy Program
Division of Oncology
The Children's Hospital of Philadelphia
Philadelphia, PA
1.00 credit

New Allocation Systems and Policy Changes for Liver Transplantation
Shivang Mehta, MD
Transplant Hepatology
Banner University Medical Center
Phoenix, AZ
1.00 credit

Blood/Marrow Transplant for Autoimmune Disease
Matthew Mei, MD
Assistant Professor
Department of Hematology and Hematopoietic Cell Transplantation
City of Hope
Duarte, CA
1.00 credit

Lung-in-a-Box: Advances in Lung Transplant Technology
Michael A. Smith, MD
Associate Chief of Thoracic Surgery
Surgical Director of Lung Transplantation
Norton Thoracic Institute, St. Joseph’s Hospital and Medical Center
Phoenix, AZ
1.00 credit

Hepatocellular Carcinoma: Treatment Options Outside of Transplant
Christopher J. Sonnenday, MD, MHS
Surgical Director of Liver Transplantation
Associate Chair for Clinical Affairs, Department of Surgery
Michigan Medicine
Ann Arbor, MI
1.00 credit

Method of participation
There are no fees for participating in or receiving credit for these activities.
For information on applicability and acceptance of continuing education credit for these activities, please consult your professional licensing board.

Participants will receive a certificate upon successful completion of each activity, which includes the following:

  • Completing the entire activity.
  • Completing the Pre- and Post-Activity Assessments, Activity Evaluation, and Application for Certificate of Credit forms.

You must be logged into your account to participate in each activity. Get started by clicking “Continue” and viewing the “CE Info”; then follow the prompts at the bottom of the screen. At the end of each activity, you will be able to view, save or print your certificate of participation. A complete listing of all of your activities can be found under “My Account”, “My Activities.”

Method for calculating CE credit
CE credit was calculated by the complexity of content.

Provided by
These activities are provided by OptumHealth Education.

Commercial support
No commercial support was received for these activities.